Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-09

Clinical Trial Update: Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use [Phase 4]

View source ↗

Summary

Phase 4 trial investigating continuation of buprenorphine/naloxone for opioid-use disorder and acute pain management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Opioid-use Disorder, Pain, Acute | Phase 4 | Status: UNKNOWN